ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Phase 4 Trials: A Critical Component Of Post-Marketing Insight

  Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

• Hope In The Dark: Value In Alzheimer's Disease Research And Treatment

  The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.

• Atlantic Research Group Builds Competitive Advantage With Medrio EDC

  By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.

• Considerations When Selecting An Interactive Response Technology Provider

  Interactive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.

• Regulatory Guidance For PRO Strategy In Oncology Trials

  Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

• How Real-Time eTMFs Are Helping Keep Trials On Track

  Learn how real-time dashboards assist with the sorting of information so clinical trial and medical affairs teams know what needs to be done, when, and by whom.

• Driving A High-Adherence LTFU Trial Without An EDC

  Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.

• Demystifying AI In Clinical Trials

  AI is revolutionizing clinical trials by improving efficiency and data quality, but success depends on strategy and oversight. Explore practical ways to integrate AI responsibly.

• Managing Risk And Regulation In Clinical Trial Technology

  Now is the time to evaluate your current risk management framework. Take action today to strengthen your safeguards, tailor your risk assessments, and prioritize transparent patient engagement.

• FDA Releases Updated Draft Guidance On Decentralized Clinical Trials

  Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.